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配体方面，除了 PK 11195，Ro5-4864 等是其经典配体但具有局限性之外，CB86
















蛋白，其亲和力约为 PK11195 的 10 倍，并且可以利用较遍及的放射性核素 99mTc
标记 CB86 从而在较便宜、普及的 SPECT/CT 下对肿瘤及炎症模型进行显像，故
CB86 被认为是一种具有很大前景且可以显像的前体。因肺癌已居全球各类肿瘤
恶性程度的首位，故本文主要研究TSPO在肺癌细胞与炎症细胞上的表达及 99mTc
标记其配体 CB86 在肺癌模型与炎症模型显像中的初步区别。 
实验方法 
首先通过 Western blot、流式细胞术观察 TSPO 抗体与正常支气管上皮细胞










Western blot、流式细胞术结果显示 TSPO 蛋白在正常支气管上皮细胞和不同
肺癌细胞株中均表达，但表达量不同。细胞免疫荧光及免疫化学染色实验表明













































Background and Purpose 
Tumor is defined once as a noncommunicable diseases like cardiovascular disease, 
diabetes or chronic respiratory diseases. Although they are considered as the augment 
of age, urbanization and unhealthy habits,then tumor gradually emerges, people 
gradually recognized that with the augment of inflammatory factors in the human 
body and with the elevation of C-reactive protein levels, inflammation is also one of 
important factors of cancer.Many studies have demonstrated that inflammation is a 
clear risk factor that can lead to cancer. The environment of Inflammation may be an 
important which can cause cancer. For example, chronic hepatitis B , hepatitis C or 
liver fluke disease can increase the risk of liver cancer. Another example is the air of 
irritating substances, such as asbestos, PM2.5 can significantly increase the risk of 
lung cancer or mesothelioma. Therefore the development of inflammation is closely 
related to a number of risk factors of tumor. 
In recent decades, the incidence and mortality of lung cancer showed a trend of rapid 
rise in most countries of the world, it is the leading cause of death in large amounts of 
common types of cancer, especially in some big cities in China and other countries in 
Europe and the United States, most of the patients with lung cancer are men, the ratio 
between men and women is 3:1 ~ 5:1, but in recent years the incidence of female 
patients with lung cancer also showed an increasing trend significantly, and lung 
cancer has become the leading cause of cancer death in the world so far. So this article 
selected lung cancer and inflammation to study preliminarily.In the aspect of lung 
cancer,the best way to treat with it is surgery, but after the surgery the survival rates 
are still low. Especially with the change in the acceleration of population aging and 
the development of living environment, the impact of lung cancer incidence and 
















improve the quality of life and prolong the life of the lung cancer patients with early 
detection, early diagnosis, accurate staging and reasonable treatment. Therefore, 
searching for new drug targets and the development of new anti-cancer drugs can 
have far-reaching effects. Now a large amount of detection of tumor and inflammation 
in the world mainly depends on traditional imaging. However, traditional imaging is 
limited by a variety of conditions. And in most cases, the imaging results of tumor and 
inflammation are similar, thus caused confusion for doctors. It also calls for a new 
probe which can distinguish tumor from inflammation, it also has profound 
significance to identify them in clinical practice. TSPO (translocator protein, 18 kDa) , 
known as peripheral benzodiazepine receptors, is mainly distributed in the 
mitochondrial outer membrane of cells, and it has high expression in both many tumor 
cells and inflammatory cells. In terms of TSPO ligand, besides PK 11195, Ro5-4864 
and so on, which are classic ligands but have their own limitations, CB86 ,as new 
ligand of TSPO, attracts more and more attention in recent years. Because CB86 can 
specifically bind to TSPO which is expressed in some kinds of cells and radionuclide 
99mTc which is pervade can labeled CB86,and its affinity is about 10 times as 
PK11195’s. so that it can image tumor and inflammation model in SPECT/CT which 
is cheap and popular. It is thought to be a target for imaging. Because lung cancer 
ranks first in various kinds of malignant tumors in the world, therefore this article 
mainly research TSPO expression in lung cancer cells and inflammatory cells and the 
imaging differences between lung cancer and inflammation model with its ligand 
CB86. 
Methods 
Firstly Western blotting and flow cytometry were used to observe binding capacity of 
normal lung cells (16HBe), lung cancer cells(A549 and NCI-H446)with TSPO 
antibody and expression amounts of TSPO in  different cells; immunofluorescence 
and cytochemistry staining detected TSPO specificity and the location in the 
cytoplasm; immunohistochemistry was used to detect the specificity of the protein 
















Micro-SPECT/CT was used to imaging effects in nude mice beared tumor;The 
octanol/water partition coefficients detected whether the marked compound is 
fat-soluble or water-soluble; In vitro stability tested the stability of the marked 
compound in saline and in the serum of mouse; In the cells, cell uptake and efflux 
assay tested the combination of the probe with the protein in the cells and the 
excretion of it; the biodistribution in mice model detected the absorption and retention 
of the probe in each organ in the body; Experimental observation probe 
Micro-SPECT/CT was used to imaging effects in inflammatory mice. 
Results 
The results of Western blotting and flow cytometry showed that the antibody has high 
affinity in lung cancer cells, and it had different amounts of expression in normal 
bronchial epithelial cell and various kinds of lung cancer cell lines. Immunochemical 
staining and immunofluorescence results showed that TSPO was localized in the 
cytoplasm of cells. The octanol/water partition coefficients showed that the compound 
99mTc-CB86 was water-soluble. In vitro stability experiment showed that the marked 
compound had no radiolysis in mice serum and physiological saline after 4 h ,so that 
it indicated in vitro stability is quite good. Cell uptake and efflux assays showed that 
the marked compound had high specific binding in macrophages and it was expelled 
from cells. The data of biodistribution found that the marked compound had specific 
uptake and nice retention. The results of imaging by Micro-SPECT/CT showed the 
imaging effects of nude mice model bearing tumor and inflammatory mice model. 
Conclusions 
1. TSPO antibody can combined with TSPO protein which is in lung cancer cells and 
tissues, normal lung cells, and macrophages.TSPO was highly expressed in these 
cells(besides normal lung cells).  
2. We succeeded in preparation of 99mTc-CB86.Its methods were simple, feasible and 
had high labeling rate, nice stability, excellent TSPO targeting and specificity. And it 
was a new promising imaging agent for diagnosing inflammation. 
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